|
CME Outfitters |
Share:
|
OverviewSince 2002, CME Outfitters has delivered over 1,400 innovative evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to primary care, specialty audiences and community-based clinicians with strong expertise in neuroscience, gastroenterology, dermatology, rheumatology, immunology, virology, transplant, and cardiology. CME Outfitters is certified as a women’s business enterprise through the Women’s Business Enterprise National Council (WBENC), the nation’s largest third-party certifier of businesses owned and operated by women in the United States. |
@MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice
Statement of Need
Gastroenterologists are trailblazers in health care social media, and #MondayNightIBD (#MNIBD) has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. #MNIBD is not just a weekly social media conversation - it is an international platform that is moving the field forward by crowdsourcing th...
|
|
@MondayNightIBD: identifying the Factors that Impact Success in Your Practice
In this webcast, CME Outfitters and @MondayNightIBD come together to bring you a panel of experts who will tailor a series of patient cases. These cases will focus on the application of cutting-edge data for novel therapies, identifying appropriate treatment strategies for special populations such as young patients and racial/ethnic minorities, and developing patient communication strategies, wi...
|
|
A Collaborative Approach to Pain: Working with Your Patients to Reach an Informed Pain Management Plan
There are currently 50 million Americans living with chronic pain, which can result in restrictions in mobility and daily activities, dependence on opioids, anxiety and depression, and reduced quality of life (QoL) leading to it being one of the most common reasons for seeking medical care. To effectively and safely manage this patient population, individualized, multimodal, and multidisciplinar...
|
|
Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management
Osteoarthritis (OA) is the most common form of arthritis, affecting 1 in 3 people over the age of 65. It is the third most rapidly rising cause of disability and the most common reason for decrease in ambulation. With the onset of the COVID-19 pandemic, the US Surgeon General has recommended cancelling elective surgeries, causing a large impact on patients with OA. A survey of 360 patients at 6 ...
|
|
Adding Tools to the Toolbox: New and Emerging Treatments for Psoriatic Arthritis
The principles of psoriatic arthritis (PsA) treatment include reducing pain, improving quality of life, preventing structural damage and complications, engaging patients in shared decision-making, and identifying comorbidities that may impact treatment decisions. This requires management by a multidisciplinary team. Novel agents and treatment targets have demonstrated efficacy in PsA. Education ...
|
|
Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis
Previously, osteoarthritis (OA) was thought to be a disease of chronic overload and impaired biomechanics on the joint that lead to the destruction of the joint's article cartilage, resulting in inflammation. However, evolving theories link OA to complex inflammatory and metabolic factors, and inadequate pain relief with current treatments is a common aspect of OA treatment which is responsible ...
|
|
All Hands: Integrating a Teams Approach to Risk-Benefit Individualization of Rheumatoid Arthritis and Psoriatic Arthritis Therapy
This CME Outfitters OnDemand webcast focuses on integrating a multidisciplinary approach to treating PsA and RA through case-based learning, with expert faculty discussing management strategies and how to integrate shared decision-making (SDM) into practice to facilitate appropriate treatment selection and empower patients.
At the end of this CE activity, participants should be able to:
- In...
|
|
Best Practices for Incorporating LAIs into Treatment Planning for Schizophrenia
Schizophrenia is an all-too-often chronic, debilitating disorder that impedes quality of life and psychosocial functioning. Implementation of effective therapy that promotes sustained recovery often poses a challenge for both clinicians and patients. Long-acting injectables (LAIs) can play a critical role in relapse prevention and rehospitalization, and subsequently, recovery and restoration of ...
|
|
Bringing UC Clinical Decision-Making into Focus for 2020: Identify the Right Treatment for the Right Patient at the Right Time
The management of ulcerative colitis (UC) is evolving. In the last 2 years, the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) released updated, evidence-based treatment guidelines with recommendations for disease stratification, prognosis, treatment options, and disease monitoring. Additionally, new efficacy, safety, and comparative effectivene...
|
|
Can We Talk: Strategies to Communicate Long-Acting Injectables (LAIs) as an Effective Treatment Option for Bipolar I Disorder
This CME Outfitters BriefCase utilizes a patient case to guide clinicians on best practices to engage patients in treatment planning for BD-I, including the feasibility of LAIs as an effective treatment option.
At the end of this CE activity, participants should be able to:
-Incorporate collaborative care discussions with patients with bipolar I disorder that include incorporating LAIs as a ...
|
|
Choosing ART: What Does the Evidence Say?
This CME Outfitters BriefCase focuses on incorporating the latest evidence-based and guideline-directed treatment strategies for a patient who has been newly diagnosed with HIV.
At the end of this CE activity, participants should be able to:
-Incorporate the latest evidence-based and guideline-directed treatment strategies in the management of patients newly diagnosed with HIV.
The follow...
|
|
Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis
Understanding patient preferences, values, and needs is essential to patient satisfaction and patient-centered care. Whether via telehealth or in-office treatment, today’s patients and their families want to be engaged in their care. This involves inclusion in personalized decision-making, education about their disease and treatment options, updates on care progress, and arriving at treatment ...
|
|
Coronavirus Disease 2019 (COVID-19) and Inflammatory Bowel Disease
The COVID-19 pandemic created many challenges and uncertainty in our healthcare system. One component facing clinicians managing patients with inflammatory bowel disease (IBD) is whether or not to continue providing certain pharmacotherapies in patients who are at increased risk of infection because they are immunocompromised. The consensus of gastroenterologists is that decisions should be made...
|
|
COVID-19 and Its Impact on Patient Care in IBD: What Clinicians Need to Know
This Live and OnDemand webcast provides clinicians with the latest information and consensus recommendations for the management of patients with IBD during the COVID-19 era. Expert faculty will also examine the latest evidence on treatment and prevention strategies for COVID-19.
At the end of this CE activity, participants should be able to:
-Examine the latest evidence on current and emergi...
|
|
COVID-19 and Its Impact on Patient Care: What Gastroenterologists Need to Know
This Live and OnDemand webcast provides clinicians with the latest information and consensus recommendations for the management of patients with IBD during the COVID-19 era. Expert faculty will also examine the latest evidence on treatment and prevention strategies for COVID-19.
At the end of this CE activity, participants should be able to:
-Apply optimal strategies to manage patients wit...
|
|
Diagnosis and Treatment of Pediatric Narcolepsy with Cataplexy
Diagnosing and managing pediatric narcolepsy with cataplexy poses a significant challenge to clinicians. In younger children, EDS may be vague and present as behavioral problems or concentration difficulties, and its treatment is considered to be similar to that of adults. Yet, the same challenges in diagnosing and treating narcolepsy in adults seem to be exacerbated in children.
Validated to...
|
|
Differentiating Psoriasis in Skin of Color
Psoriasis (PsO) is a chronic, inflammatory skin disorder affecting about 1%-3% of the world's population. There are many challenges in diagnosing and successfully managing individuals with PsO. For example, while there are similarities in PsO among ethnic groups, there are notable differences in presentation, quality of life, and treatment of PsO in people with skin of color.
The first episod...
|
|
Differentiators When Choosing Novel Treatment Options for EDS
Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In order to achieve reduced EDS, cataplexy and sleep paralysis/hypnagogic hallucinations must be controlled to improve disturbed nighttime sleep, which then improves fatigue and brain fog and reduces psychosocial dysfunction, therefore improving quality of lif...
|
|
Eliminating Diagnostic Delays in Psoriatic Arthritis
Psoriatic arthritis (PsA) is a progressive, erosive, chronic, heterogeneous, systemic inflammatory disease affecting six different clinical domains and presents in up to 30% of patients with psoriasis (PsO). Beyond issues caused with joints and skin, PsA can also lead to fatigue, poor sleep quality, diminished work capacity, physical function limitations, and decreased social participation. Earl...
|
|
Evidence-Based Strategies to Improve Access to Therapies for Patients with Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is both a rare disease and the most common fatal genetic disease of infancy. The approval of the first disease-modifying therapy (DMT) for SMA in 2016 revolutionized management, and treatment options have expanded with two additional DMTs approved more recently. However, because SMA is a rare disease, many clinicians and payers have limited knowledge of SMA and the ...
|
|
Finding Function: A Holistic Approach to Managing Osteoarthritis
There are several different approaches to treating osteoarthritis (OA), including physical, psychosocial, and mind-body. It is important that primary care physicians work in concert with rheumatologists, physical/occupational therapists, psychologists, and dietitians to create a multidisciplinary management plan for their patients with OA, as well as participating in shared decision-making.
I...
|
|
Finding Your Footing in the Shifting Landscape of Multiple Sclerosis
In this CME Outfitters Live and OnDemand webcast, animated 3-D models will illustrate the immune processes that contribute to MS pathology and serve as targets for immune-directed therapies. Expert faculty will review clinical data supporting the efficacy and safety of novel and emerging immune-directed therapies as well as the role of biomarkers in assessing disease progression and guiding trea...
|
|
From Bench to Bedside: Applying Clinical Updates to Schizophrenia Management
Per APA Guidelines, treatment goals for schizophrenia include avoiding relapses and exacerbations that can cause immense negative impact on quality of life (QoL). Long-acting injectables (LAIs) are an effective tool for achieving these goals in both acute and chronic phases of illness; however, there is often reluctance to implement their use. A better understanding of the safety and efficacy of...
|
|
HBV Treatment Decision-Making
Chronic hepatitis B virus (HBV) is a serious public health concern that is often underrated despite the approval of newer therapies and subsequent updated guidelines. Integrating guideline-directed treatment can reduce the morbidity and mortality associated with HBV.
In this second episode of the four-part CMEOCast Podcast to Practice series "Meeting Patients Where They Live: Community-Based ...
|
|
I Shouldn't Be This Sleepy: A Look into EDS
Patients with narcolepsy can have a wide range of medical comorbidities, which contribute to the burden of disease as well as under diagnosis. Additionally, excessive sleepiness may persist despite patients using their CPAP for ≥ 6 hours per night. Early detection of and treatment initiation for EDS is imperative; therefore, clinicians should query their patients abut sleep, identify EDS with ...
|
|
Immune Pathways in Systemic Lupus Erythematosus (SLE)
Lupus is a prototypic autoimmune disease with highly heterogeneous manifestations and variable disease activity in which no two cases are alike. Differences can be caused by genetics and epigenetics, pathogenetic mechanisms, demographics, ethnicity and race, as well as socioeconomic factors, and disease heterogeneity can cause challenges with development and selection of therapeutics, perfection...
|
|
Implementing a Shingles Protocol in Pharmacies
Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles va...
|
|
Implementing a Shingles Protocol in Primary Care Settings
The first episode of this CMEOCast podcast series focuses on reinforcing the importance of vaccination against shingles, improving vaccination uptake in ethnic minorities and at-risk patients, and developing best practices to implement a shingles protocol in primary care settings.
At the end of this CE activity, participants should be able to:
-Develop best practices to implement a shingles ...
|
|
Implementing a Shingles Protocol in Specialty Practices
This CMEOCast podcast focuses on best practices to increase vaccine uptake and completion in vaccine-eligible patients and those at risk who present to specialty settings. The podcast will address ideal strategies to store and administer RZV, counseling patients on the extensive burden associated with shingles, and the benefits and potential risks of vaccination.
At the end of this CE activit...
|
|
Initiating Medication-Assisted Therapy for OUD in Diverse Settings: Clinical Pearls for Navigating the Process
The opioid abuse epidemic has resulted in an alarming increase in opioid-related overdoses and deaths; however, the severe and lethal consequences of opioid misuse is preventable with the use of medication-assisted treatment (MAT), which is a proven, effective tool for patients with opioid use disorder (OUD).
Research has demonstrated that MAT is effective in reducing opioid use and overdoses...
|
|
Joining Forces in the Coordination of Care of Patients with Psoriatic Arthritis
Delays in diagnosing psoriatic arthritis (PsA) are common, with the median lag time from disease onset to a confirmatory diagnosis being 2.5 years. It is imperative that clinicians recognize the impact of delays in diagnosis on joint damage and patient quality of life, and that a multidisciplinary approach can help with earlier diagnosis and better management of PsA and its comorbidities.
The...
|
|
Laying to Rest Challenges in Managing Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea or Narcolepsy- An Augmented Reality Experience
Excessive daytime sleepiness (EDS) is a common symptom of obstructive sleep apnea (OSA) and narcolepsy. EDS is often associated with traffic accidents and occupational incidents, cognitive impairments, and increased risk of medical and psychiatric comorbidities, resulting in poorer quality of life (QoL) and increased mortality. Yet, the burden of EDS is often underestimated and devising effectiv...
|
|
Long-Term Management of HBV: Meeting the Culturally Diverse Needs of Your Patient Community
Despite the high prevalence of hepatitis B virus (HBV) in the United States, only 32% of patients are aware of their HBV status and less than 30% receive treatment. There are six groups who are at especially high risk: foreign-born Asian/Pacific Islanders, Africa-born Black populations, incarcerated persons, people who inject drugs, men who have sex with men, and refugees. Disease awareness is e...
|
|
Managing Neurologic Disease in the Era of Covid-19: Focus on Botulinum Toxin
In response to the spread of COVID-19, it is important to develop a plan for effective and timely patient triage. Especially for patients with spasticity, this initial assessment must factor in quality of life (QoL). It is also critical to provide the appropriate level of care to all patients, irrespective of COVID-19 infection status. Along with assessing QoL, clinicians must ensure medication ...
|
|
Managing Your MS Patients in the Era of COVID-19
While MS itself does not increase the risk of contracting COVID-19, treatment decisions should be individualized and made collaboratively between the patient and his or her healthcare provider during the current pandemic. It is imperative that clinicians recognize which patients will benefit from which disease-modifying therapies (DMTs), and that they address patient concerns and provide tools o...
|
|
Matching Treatment Choice to the Pathophysiology of Sleep
The neurobiology of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) has no identified pathophysiology. This can make it difficult for clinicians to determine a target for therapeutic intervention; therefore, awareness of the mechanisms of action of current and novel therapies is vital when selecting an optimal treatment.
In the second episode of this CME Outfitters podcast...
|
|
Matching Treatment Options to the Patient: The Role of Botulinum Toxin in Pediatric Patients with Spasticity
Spasticity, a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, results from hyper excitability of the stretch reflex. It often causes damage to one or more areas of the central nervous system; therefore, treatment goals should aim to provide symptom relief, ease patient care and decrease caregiver burden, and improve patient f...
|
|
Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
Psoriatic arthritis (PsA) can have serious debilitating effects on peripheral joints, the spine, tendon insertions, and fingers. Management of PsA has improved with therapies such as nonpharmacologic and symptomatic treatments, oral small molecules, tumor necrosis factor inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, CTLA4-lg, Janus kinase (JAK)/TyK2 inhibitors, and IL-23 inhib...
|
|
Missed Opportunities: Tools, Tips, and Techniques to Improve the Detection of Bipolar I Disorder
In this CME Outfitters BriefCase, expert faculty will present a patient case that shows how to detect BD-I, differentiate BD-I and BD-II and other mimickers, and use evidence-based screening tools to improve detection of BD-I in order to promote early administration of effective care.
At the end of this CE activity, participants should be able to:
-Implement diagnostic criteria and evidence-...
|
|
Myth Busting about NSAIDs and Bone Health
Nonsteroidal anti-inflammatory drugs (NSAIDs) have recently become one of the top post-procedure pain management recommendations, and in most cases, a suitable replacement to the use of opioids. Unfortunately, myths about NSAIDs inhibiting bone healing and increasing fracture risks are prevalent, despite the lack of clinical evidence that NSAIDs impair healing.
The third episode of this CMEOC...
|
|
Pathogenesis of Psoriatic Arthritis: A Broader Understanding to Inform Next Steps
Psoriatic arthritis (PsA) presents in up to 30% of patients with psoriasis (PsO) and may precede, occur concurrently with, or occur after the development of PsO. It is imperative to recognize that PsA can present in the dermatology or rheumatology clinic depending on the primary symptom and that clinicians then accurately diagnose PsA by utilizing screening questionnaires, as well as screening p...
|
|
Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care
Screening for hepatitis B virus (HBV) in the emergency department (ED) is an important public health opportunity, as it can reduce transmission in high-risk patients and facilitate linkage to care. HBV testing can be included when screening for sexually transmitted infections (STIs) and hepatitis C virus (HCV), and emergency department (ED) physicians to employ strategies for follow-up, includin...
|
|
Pull the Levers That You Can: Managing HIV in an Aging Population
In this CME Outfitters BriefCase, expert faculty will present a patient case focusing on the impact of comorbidities and how to individualize treatment regimens for aging patients with HIV, based on their specific needs and comorbidities.
At the end of this CE activity, participants should be able to:
-Individualize treatment regimens for aging patients with HIV, based on their specific need...
|
|
Rethinking Routines in Multiple Sclerosis Management: What the Future Holds for DMTs and Cognitive Assessment Strategies
Multiple sclerosis (MS) is a chronic inflammatory and neurological disease that is the leading cause of disability in young and middle-aged people in the United States. The number of disease-modifying therapies (DMTs) available for treatment of MS has expanded in recent years, and it is imperative that neurologists and other health care professionals (HCPs) have up-to-date knowledge of clinical ...
|
|
Risk for Opioid Overdose: Identifying At-Risk Patients in Your Practice Hidden in Plain Sight
The objective of this webcast is to raise awareness about the risk of overdose among patients with chronic pain in everyday practice and actionable changes to practice that are needed to mitigate that risk.
At the end of this CE activity, participants should be able to:
-Recognize the distinct patient profiles of individuals at risk of opioid overdose
-Initiate discussions about overdose ri...
|
|
Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)
When measuring outcomes in systemic lupus erythematosus (SLE), it is important for clinicians to monitor disease activity, health-related quality of life, and any irreversible change in the organ system that occurred since the onset of SLE. While there are currently many therapies utilized in treating SLE, such as nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antimalarials, immunosupp...
|
|
Saturday Morning Coffee with Experts in NASH: What Is The Update?
In this CME Outfitters webcast, a renowned panel of experts will highlight the underlying mechanisms of NASH via innovative augmented reality (AR) animations and present real-world case scenarios to share clinical insights on how to choose appropriate non-invasive diagnostic modalities, as well as translate latest data on emerging targeted therapies and their implications for clinical practice.
...
|
|
Seeing Osteoarthritis Management Through a New Mechanistic Lens
Inadequate pain relief despite current treatments is one of the most troubling aspects of osteoarthritis (OA), and is responsible for the majority of health care visits in patients with OA. Additional concerns about the risks of long-term NSAID and opiate use contribute to unmet treatment needs. It is therefore necessary for clinicians to recognize the role of novel targets for pain management, ...
|
|
Signals of Change in the Management of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that effects up to 18% of children and up to 10% of adults and can have a substantial negative impact on the quality of life (QoL) of patients and their families. Its management is challenging at any age, with patients and caregivers often becoming overwhelmed by the chronic and relapsing nature of AD. Establishing disease severity i...
|
|
Spasticity: Diagnosis and Management with Focus on Botulinum Toxin
This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 - 29, 2020.
At the end of this CE activity, participants should be able to:
-Recognize the varied presentations of spasticity.
-Develop individualized treatment strategies based on shared goals and available treatment opt...
|
|
Streamlining the Journey to a Cure: Optimizing the Hepatitis C Virus Care Cascade
Hepatitis C virus (HCV) is a major cause of cirrhosis, liver cancer, and mortality worldwide. The opioid crisis has caused a rise in injection drug use, which has contributed significantly to the increase in HCV infections. The United States experienced a 238% increase in new HCV infections between 2010 and 2016, which has led to a goal to eliminate hepatitis by treating 80% of patients with hep...
|
|
Switching and Monitoring Your Patients with RRMS
Predictors of poor prognosis in multiple sclerosis (MS) can include demographic and environmental factors, clinical factors, MRI observations, and biomarkers. Early initiation of appropriate therapy is key when personalizing treatment for relapsing-remitting multiple sclerosis (RRMS), as is having a plan to determine sub-optimal responders, approaches to switching or escalating therapy, and cons...
|
|
Talking Safety and NSAIDs
There are many myths surrounding the use of nonsteroidal anti-inflammatory drugs (NSAIDs), and while it is important to dispel these myths, it is also imperative to understand what risks might be involved. NSAIDs, like all medications, carry the potential for side effects and other dangers that must be understood for effective use in pain management.
Following the CMEOCast podcast episode tha...
|
|
The HBV Refresher: Screen, Diagnose, Treat
Despite updated guidance from the American Association for the Study of Liver Diseases (AASLD) on the prevention, diagnosis, and treatment of chronic hepatitis B virus (HBV), early detection and implementation of effective treatment remains a challenge.
The first episode of this CMEOcast series on community-based efforts to improve screening and treatment of HBV will guide primary care clinic...
|
|
The Importance of Care Coordination for Patients with Psoriatic Arthritis
Psoriasis (PsO) and psoriatic arthritis (PsA) are complex disorders that require coordinated care between dermatologists and rheumatologists. Challenges to effective management include a lack of education of patients and health care providers (HCPs), suboptimal communication, and clinicians' lack of a holistic treatment approach.
The third episode of this BriefCase series on challenging cases...
|
|
The Road to Remission: Assessing Today's Treatment Goals in Crohn's Disease
Crohn’s disease (CD), an inflammatory bowel disease (IBD) that affects at least 780,000 people in the United States, has recently seen its management goals evolve from merely controlling flares to achieving and sustaining deep remission, which can help a patient avoid progressive bowel wall damage. The only treatments effective in achieving durable deep remission are novel targeted therapies, ...
|
|
The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer: Guidance for Today and the Path Forward
In this CME Outfitters Live and OnDemand, integrations of animated 3-D models will provide visual representation of the mechanisms and characteristics of antibody drug conjugates (ADCs) in NSCLC to complement expert faculty insights and evidence supporting testing strategies to identify predictive biomarkers, emerging treatment options for advanced or metastatic NSCLC, and best practices for man...
|
|
The Role of Race in Health Care Delivery in IBD
Although IBD is more common in non-Hispanic Whites compared to other racial groups, there is a disproportionately higher ratio of hospitalizations, surgery, and IBD-related mortality among non-Hispanic African Americans compared with other racial groups. This fact, in addition to the rising prevalence of IBD in North America and the estimate that 54% of the U.S. population will be comprised of m...
|
|
The Role of Socioeconomic Factors in Health Care Delivery in IBD
Certain patients with IBD are more likely to see poor outcomes due to low socioeconomic status (SES). Recognizing and acting on these differences is especially important during the COVID-19 pandemic, the economic consequences of which have disproportionately affected those with low SES.
In the second episode of this CMEOCast podcast series, expert faculty focus on the role of SES and gender b...
|
|
Translating Evidence to Practice: Approaches for Individualism and Patient-Centered MS Care
This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 - 29, 2020.
At the end of this CE activity, participants should be able to:
-Evaluate the latest clinical data on the safety and efficacy of current and emerging therapies for MS and develop a patient centered care plan.
|
|
Ulcerative Colitis in the 21st Century: Incorporating Guidelines and Real-World Evidence in Practice to Enhance Patient-Centered Care
Ulcerative colitis (UC) is a heterogeneous disorder that requires an individualized approach in order to achieve goals of treatment such as mucosal healing and deep, long-term remission. The American College of Gastroenterology (ACG) released updated treatment guidelines in 2019 that include recommendations for disease stratification, prognosis, treatment options, and disease monitoring. These g...
|
|
Unique Approaches to the Management of Underserved Patients with IBD
There are many disparities in irritable bowel disease (IBD) care, with an incidence rate of IBD hospitalization that is 4x higher in patients with low socio-economic status and a 3x increased ratio of IBD hospitalizations and mortality in Blacks compared to Whites and Hispanics.
The final episode of this CMEOCast podcast series summarizes the discussion points on the racial/ethnic and economi...
|
|
Unlocking the Value of Biosimilar Therapies in IBD
Over the years, biologic agents have proven their importance in the management of chronic autoimmune diseases including inflammatory bowel disease (IBD). Biosimilars are molecules highly similar to approved biologic medicines that have been developed to mitigate the high costs of biologics. Despite the fact that these therapies are tested to ensure non-inferiority to originator products, questio...
|
|
Updates on the Management of Insomnia: Expert Guidance Through the Latest Clinical Trials on Dual Orexin Receptor Antagonists
This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 - 29, 2020.
Learning Objectives
At the end of this CE activity, participants should be able to:
Query your patients about insomnia to facilitate diagnosis and treatment to reduce the personal, clinical, and societal bur...
|
|
Weighing the Evidence: A Pharmacy Approach to Stroke Prevention in Obese Patients with Non-Valvular Atrial Fibrillation
In this CME Outfitters virtual symposium, expert faculty review key aspects of the prescribing information, guidelines, and recently published safety and efficacy data for DOACs and warfarin in order to enable pharmacists and other clinicians to support evidence-based therapeutic treatment decisions in obese patients with NVAF.
At the end of this CE activity, participants should be able to:
...
|
|
Weighing the Heavy Burden of Osteoarthritis: Improving Function and Quality of Life
The burden of osteoarthritis (OA) is a heavy one, often leading to poor quality of life (QoL) due to functional limitations and loss of independence, poor sleep quality, fatigue, depressed mood, and increased healthcare expenditures. Additionally, comorbidities such as stroke, peptic ulcer, and metabolic syndrome must be considered. Therefore, proper assessment of a patient's OA, the pain it cau...
|
|
When Is Switching ART Necessary?
In this CME Outfitters BriefCase, faculty will highlight a patient case that focuses on seizing opportunities to optimize and simplify treatment for patients with human immunodeficiency virus (HIV) while maintaining virologic suppression, as well as best practices for engaging patients in shared decision-making so that patient preference is always considered.
At the end of this CE activity, p...
|
|